Harvard Bioscience Completes Acquisition of Data Sciences International

Harvard Bioscience (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, announced today that the Company has completed the previously announced acquisition of Data Sciences International.

As quoted in the press release:

Simultaneous to the acquisition of DSI, the Company entered into a credit facility with Cerberus Business Finance, LLC, as administrative agent and collateral agent for the lenders (the “Credit Facility”).  The Credit Facility is comprised of a $64 million term loan and a $25 million revolving line of credit, of which approximately $4.8 million was drawn at closing.

Click here to read the full press release.